Globe Life Inc.
GL Financial Services Insurance - Life NYSE
$142.18
$-1.19 (-0.83%)
Open: $143.22 | High: $143.22 | Low: $138.86 | Prev Close: $143.37
Market Cap: $11.32B
Volume: 465K | Avg: 507K
Last updated: March 09, 2026 at 02:02 AMInvestment Rating
Buy
Overall Score: 80/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 612
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | 10.10 |
| P/B Ratio | 1.92 |
| P/S Ratio | 1.89 |
| EPS | $14.08 |
| Beta | 0.46 |
| Shares Outstanding | 79.61M |
| 52-Week High | $152.71 |
| 52-Week Low | $109.38 |
| SMA 50 | $142.11 |
| SMA 200 | $134.94 |
| Dividend Yield | 0.76% |
| Annual Dividend | $1.08 |
| Next Earnings | April 29, 2026 08:00 PM ET |
Financial Ratios
| Gross Margin | 33.4% |
| Operating Margin | 24.4% |
| Net Margin | 19.4% |
| ROE | 20.6% |
| ROA | 3.8% |
| Debt/Equity | 0.44 |
| Current Ratio | 0.62 |
| Quick Ratio | 0.62 |
Balance Sheet
| Total Assets | $30.81B |
| Total Liabilities | $24.84B |
| Total Equity | $5.97B |
|
|
|
| Cash | $144.70M |
| Total Debt | $2.63B |
| Net Debt | $2.48B |
Income Statement
| Revenue | $6.00B |
| Gross Profit | $2.00B |
| Operating Income | $1.46B |
| Net Income | $1.16B |
|
|
|
| EBITDA | $1.59B |
| Revenue/Share | $74.19 |
Cash Flow
| Operating CF | $1.40B |
| CapEx | $142.48M |
| Free Cash Flow | $1.25B |
|
|
|
| Book Value/Share | $73.90 |
| Tangible Book/Share | $67.83 |
| Equity/Share | $73.90 |
Technical Indicators
| RSI (14) | 40.16 Neutral |
| MACD |
0.48
Signal: 0.79
|
| Volatility | 22.76% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | +16.34% |
| Sharpe Ratio | 0.73 Fair |
| Volatility (Ann.) | 21.79% Moderate |
| GL (1Y) | +16.34% |
| S&P 500 (1Y) | +13.03% |
| Alpha (Excess Return) | +3.31% |
Sector Comparison (Financial Services)
| Metric | GL | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | 10.1 | 47.92 | 8% |
| P/B Ratio | 1.92 | 4.21 | 43% |
| ROE (%) | 20.64% | 19.70% | 71% |
| Net Margin (%) | 19.36% | 18.73% | 63% |
| Stock Score | 612 | 428.0 | 94% |
| 1Y Return (%) | +16.34 % | +7.92 % | 80% |
📊 Historical Price Analysis (Last 200 Days)
Loading chart...
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GL | $142.18 | $143.63 | $143.74 | $143.65 | $141.98 | $134.91 | 40.16 | 0.48 | 22.76% | 84452 | Weak Short | Price Below SMAs |
Candlestick Patterns
There wasn't any recognizable pattern for the GL stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| GL | Did Globe Life Inc. Insiders Breach their Fiduciary Duties to Shareholders? | Neutral | prnewswire.com | Read More |
| GL | Globe Life (NYSE:GL) CEO Sells $2,657,941.80 in Stock | Neutral | defenseworld.net | Read More |
| GL | Why Is Globe Life (GL) Down 2.4% Since Last Earnings Report? | Neutral | zacks.com | Read More |
| GL | 3 Resilient Sales Growth Stocks for Navigating a Risk-Off Market | Positive | zacks.com | Read More |
| GL | 4 Dividend Stocks Boost Payouts as Investors Seek Safety in a Volatile Market | Neutral | zacks.com | Read More |
Recent Insider Trading
No recent insider trading data available for GL
Company Information
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle to middle income households in the United States. The company operates through four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole life, term life, and other life insurance products; Medicare supplement and supplemental health insurance, such as critical illness and accident plans; and single-premium and flexible-premium deferred annuities. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was incorporated in 1979 and is headquartered in McKinney, Texas.
| CEO | Frank Martin Svoboda |
| Employees | 3732 |
| Country | US |
| IPO Date | 1980-10-01 |
| Exchange | NYSE |
| Website | https://www.globelifeinsurance.com |
| Sector | Financial Services |
| Industry | Insurance - Life |
Similar Stocks (Financial Services - Insurance - Life)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category